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SUMMARY
The protective effects of the tuberculosis vaccine
Bacillus Calmette-Guerin (BCG) on unrelated infec-
tions are thought to be mediated by long-term meta-
bolic changes and chromatin remodeling through
histone modifications in innate immune cells such
as monocytes, a process termed trained immunity.
Here, we show that BCG induction of trained immu-
nity in monocytes is accompanied by a strong in-
crease in glycolysis and, to a lesser extent, gluta-
mine metabolism, both in an in-vitro model and
after vaccination of mice and humans. Pharmaco-
logical and genetic modulation of rate-limiting
glycolysis enzymes inhibits trained immunity,
changes that are reflected by the effects on the his-
tone marks (H3K4me3 and H3K9me3) underlying
BCG-induced trained immunity. These data demon-
strate that a shift of the glucose metabolism toward
glycolysis is crucial for the induction of the histone
modifications and functional changes underlying
BCG-induced trained immunity. The identification
of these pathways may be a first step toward vac-
cines that combine immunological and metabolic
stimulation.
INTRODUCTION
The live attenuated Bacillus Calmette-Guerin (BCG) vaccine
confers protection against severe forms of Mycobacterium
tuberculosis infection while having a limited effect against pul-
monary tuberculosis (Colditz et al., 1994; Zumla et al., 2013). In
addition to its effects on tuberculosis, it has also been shown
that vaccination with BCG leads to non-specific protective ef-
fects against non-related infections and mortality. In observa-
tional studies in West Africa, it was shown that the presence
of a BCG scar or PPD (purified protein derivative) positivity is
associated with reduced child mortality (Garly et al., 2003;
Roth et al., 2005). Furthermore, in two randomized controlled
trials, early administration of the BCG vaccination reduced
child mortality, mainly as a result of less neonatal sepsis and
lower respiratory infections (Aaby et al., 2011; Biering-Søren-
sen et al., 2012; Kristensen et al., 2000). BCG is also used to
treat bladder cancer and appears to be beneficial in treating
several other diseases or conditions, such as warts, leishman-
iasis, and asthma (Pereira et al., 2009; Rousseau et al., 2008;
Salem et al., 2013). As further proof of its non-specific protec-
tive effects, BCG was shown to protect mice against lethal
candidiasis (van ’t Wout et al., 1992), and, interestingly, this
protective effect was also present in SCID (severe combined
immunodeficiency) mice, therefore showing that this non-spe-
cific protection is T and B cell independent (Kleinnijenhuis
et al., 2012). It was found that these effects are mediated by
the functional and epigenetic reprogramming of innate immune
cells such as monocytes, macrophages, and NK (natural killer)
cells, a process termed ‘‘trained immunity’’ (Netea et al., 2011,
2016).
We have recently demonstrated that induction of trained
immunity by fungal components such as b-glucan leads to
a shift of cellular metabolism from oxidative phosphorylation
toward glucose fermentation (Cheng et al., 2014; Saeed
et al., 2014). This is a process mediated through the Akt/
mTOR (mammalian target of rapamycin)/HIF1a (hypoxia-
inducible factor 1a) pathway, which is crucial for an effective
induction of trained immunity (Cheng et al., 2014; Saeed
et al., 2014). Similar observations on the importance of meta-
bolic changes during immune cells activation have been made
by others: proinflammatory—e.g., M(interferon [IFN]g)—mac-
rophages are characterized by increased glycolysis and
lactate production, whereas the more anti-inflammatory—
e.g., M(interleukin [IL]-4)—macrophages seem to rely on
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oxidative phosphorylation, fatty acid uptake, and b-oxidation
(Odegaard and Chawla, 2011). In contrast monocytes from pa-
tients suffering from sepsis-induced immunoparalysis show
reduced pro-inflammatory cytokine production with a defec-
tive capacity to mount glycolysis and b-oxidation (Cheng
et al., 2016).
So far, however, no data have been reported regarding cellular
metabolism in BCG-induced trained immunity. In this study, we
used in vitro and in vivo (both mice and human) models of trained
immunity (Kleinnijenhuis et al., 2012) to assess the changes in
cellular metabolism pathways that underlie BCG-induced
trained immunity and its effects on cytokines and epigenetic (his-
tone) changes. Deciphering the role of metabolic pathways for
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Figure 1. Role of Glucose Metabolism for
the Induction of BCG-Induced Trained
Immunity
(A) Graphical outline of the in vitro methods.
(B) Monocytes were incubated for 24 hr with culture
medium or BCG and then allowed to rest for 2 days
and stimulated for 24 hr with LPS in medium
with 13C-labeled glucose. Glucose consumption
from the medium, lactate production, and their
ratios were determined. Also, incorporation of the
13C-label in lactate was determined (mean ± SD,
n = 3). *p < 0.05, Student’s t test.
(C)Monocyteswere incubated for 24 hr with culture
medium or BCG. At day 6 (prior to restimulation),
extracellular acidification rate (ECAR) and oxygen
consumption rate (OCR) were determined by
Seahorse (mean ± SEM, n = 6). *p < 0.05, Wilcoxon
signed-rank test.
(D) Mice were vaccinated with BCG. After 7 days,
splenocytes were isolated, and ECAR and OCR
were determined by Seahorse (mean ± SEM, n = 6).
*p < 0.05; **p < 0.01, Mann-Whitney test.
(E) Monocytes were incubated for 24 hr with culture
medium or BCG. At day 6 (prior to restimulation),
intracellular concentrations of glutamate, fumarate,
malate, and acetyl-CoA were determined (mean ±
SEM, n = 6). *p < 0.05, Wilcoxon signed-rank test.
See also Figures S1–S4.
the non-specific effects of BCG vaccina-
tion may lead to a better understanding
of the induction of trained immunity and
how modulation of cellular metabolism
pathways may be used to boost the effect
of vaccines.
RESULTS
Glucose Is aMain Energy Source for
BCG-Trained Monocytes
To assess glycolytic rate, a well-estab-
lished in vitro method of trained immunity
was used (Kleinnijenhuis et al., 2012;
Quintin et al., 2012). Human monocytes
were incubated for 24 hr with BCG, or
RPMI medium as a control, and restimu-
lated after a subsequent 5 days of rest
with lipopolysaccharide (LPS) or RPMI medium for 24 hr (Fig-
ure 1A). Glycolytic rate was assessed by measuring glucose
consumption from the medium, and lactate production was
used to measure the fermentative capacity, 24 hr after LPS stim-
ulation. Both glucose consumption and lactate release were
increased, reflecting the induction of glycolysis (Figure 1B).
The ratio of lactate:glucose in BCG-trained macrophages was
close to 2, suggesting that these cells use glucose as the major
source of lactate, whereas in non-trained macrophages
(showing a higher ratio), other substrates were used as well (Fig-
ure 1B; Figure S1). As further proof, priming with BCG signifi-
cantly increased incorporation of 13C in lactate during the 24 hr
of restimulation with LPS (Figure 1B; Figures S2A and S2B).
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Incorporation of 13C-labels was also increased in rybosyl-1,
which is suggestive of an induction of the pentose phosphate
pathway (Figure S2C). Assessment of BCG-trained monocytes
on day 6 (prior to restimulation) using Seahorse technology
showed an increased basal and maximal extracellular acidifica-
tion rate (ECAR) as a measure of lactate production. Interest-
ingly, however, the oxygen consumption rate (OCR, as a
measure for oxidative phosphorylation) was also increased (Fig-
ure 1C; Figure S3A). This is different compared to b-glucan
trainedmacrophages, which have shown a classical Warburg ef-
fect (with increased glycolysis and decreased oxidative phos-
phorylation) (Cheng et al., 2014). These data were validated in
mice, where BCG led to an upregulation of ECAR and OCR in
splenocytes 1 week after vaccination (Figure 1D; Figure S3B).
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Figure 2. Akt/mTOR Activation and Induc-
tion of BCG-Induced Trained Immunity
(A) Monocytes were incubated for 2 hr with BCG
or control medium, and phosphorylated Akt
was assessed by western blot and quantified
(mean ± SEM, n = 5). *p < 0.05, Wilcoxon signed-
rank test.
(B)Monocytes were incubated for 24 hr with culture
medium or BCG, with or without Wortmannin. At
day 6, after restimulation with LPS, IL-6 and TNF-a
concentrations in the supernatants were measured
(mean ± SEM, n = 6). *p < 0.05, Wilcoxon signed-
rank test.
(C) Monocytes were incubated for 24 hr with
culture medium or BCG. At day 6 (prior to re-
stimulation), phosphorylation of mTOR, S6K, and
4EBP1 was assessed by western blot and quan-
tified (mean ± SEM, n = 5). *p < 0.05, Wilcoxon
signed-rank test.
(D–F) Monocytes were incubated for 24 hr with
culture medium or BCG, with or without the meta-
bolic modulators of glycolysis/mTOR (D), TCA/
OxPhos (oxidative phosphorylation) (E), glutamine
metabolism or pentose phosphate pathway (PPP)
(F). At day 6, IL-6 and TNF-a production was
determined in the supernatants after restimulation
with LPS (mean ± SEM, n = 6). *p < 0.05, Wilcoxon
signed-rank test.
(G) Monocytes were incubated for 24 hr with
culture medium or BCG. Culture media with 2, 1,
or 0 mM of L-glutamine were used. At day 6,
IL-6 and TNF-a production in the supernatants
were determined after restimulation with LPS
(mean ± SEM, n = 6). *p < 0.05, Wilcoxon signed-
rank test.
Besides glucose, other metabolites can
be used for energy and carbon meta-
bolism. Therefore, we assessed amino
acid utilization at several time points, but
none were significantly increased (Fig-
ure S4). Interestingly, intracellular concen-
trations of glutamate and malate (but not
fumarate), metabolites that can be pro-
duced from glutamine, were increased.
In contrast, concentrations of acetyl-co-
enzyme A (CoA), a central metabolite link-
ing glycolysis and fatty acid metabolism with trichloroacetic acid
(TCA) cycle, were not modulated by BCG training (Figure 1E).
Metabolic Changes and Trained Immunity Are
Dependent on Activation of the Akt-mTOR Pathway
We previously showed that the shift toward a higher glycolytic
rate in b-glucan-induced trained monocytes is dependent on
the Akt/mTOR pathway (Cheng et al., 2014). Supporting a similar
pathway in BCG-induced trained immunity, we found that mono-
cytes that were primed for 2 hr with BCG showed an increased
Akt phosphorylation (Figure 2A). Inhibition of Akt by Wortmannin
during the first 24 hr of BCG training abrogated the increase in
cytokine production by LPS restimulation at day 6, confirming
the essential role of Akt for induction of trained immunity
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(Figure 2B). BCG-induced training of monocytes also led to the
phosphorylation of mTOR and its targets S6K and 4EPB1, as
determined at day 6 (Figure 2C), and inhibition of mTOR and
glycolysis by rapamycin, torin, AICAR, and 2-deoxyglucose
(2-DG) during BCG training abrogated the increased cytokine
production (Figure 2D). Similar effects were observed with the
addition of metformin that has more broad metabolic effects
on both glycolysis and oxidative phosphorylation (Figure 2D).
Addition to the medium of dichloroacetate (DCA), which inhibits
pyruvate dehydrogenase kinases and, thus, shifts glucosemeta-
bolism toward the TCA cycle (Cairns et al., 2007), abrogated the
induction of cytokine production. In contrast, the inhibition of the
electron transport chain by thecomplexV inhibitor oligomycin did
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Figure 3. Epigenetic and Metabolic Regula-
tion in BCG-Induced Trained Immunity
Monocytes were incubated for 24 hr with culture
medium or BCG. At day 6 (prior to restimulation):
(A) mRNA expression of mTOR and two rate-
limiting enzymes in glycolysis (HK2, and PFKP) and
glutamine metabolism (GLS and GLUD) were
determined (mean ± SEM, n = 6). *p < 0.05, Wil-
coxon signed-rank test.
(B) DNAwas isolated, andH3K4me3 andH3K9me3
were determined at promoter sites of MTOR, HK2,
PFKP, GLS, and GLUD (mean ± SEM, n = 6). *p <
0.05, Wilcoxon signed-rank test.
(C and D) H3K4me3 (C) or H3K9me3 (D) was
determined at promoter sites of TNFA and IL6.
During the first 24 hr, inhibitors of glutamine
metabolism (BPTES) or mTOR/glycolysis (rapa-
mycin) were added (mean ± SEM, n = 6). *p < 0.05,
Wilcoxon signed-rank test.
See also Table S1.
not have an effect on the induction of
trained immunity (Figure 2E). Inhibition of
glutamine metabolism by BPTES also
abrogatedcytokineproduction (Figure2F).
Decreasing glutamine concentration in the
medium also inhibited the induction of
cytokine production after restimulation
with LPS (Figure 2G), showing that gluta-
mine utilization is essential for the induc-
tion of trained immunity. Inhibition of the
pentose phosphate pathway by 6-amino-
nicotinamide had no effect on the induc-
tion of training (Figure 2F). Thus, the Akt-
mTOR pathway—which, in turn, drives
glucose and glutamine metabolism—is
crucial for BCG-induced trained immunity.
Epigenetic Regulation of
Metabolism
To further assess how glucose and gluta-
mine metabolism are regulated in BCG-
trained monocytes and macrophages,
mRNA expression of mTOR and four
essential enzymes in glycolysis and gluta-
mine metabolism were determined at day 6 after BCG training.
mTOR and all four enzymes were upregulated in trained mono-
cytes prior to restimulation (Figure 3A). To investigate whether
this increased expression was a result of epigenetic changes,
histone 3 trimethylation of lysine 4 (H3K4me3) and lysine 9
(H3K9me3) were determined. Both these two histone marks
have been previously shown to be important in BCG-induced
trained immunity, with H3K4me3 being a histone mark denot-
ing open chromatin and increased gene transcription, while
H3K9me3 is a repressor mark (Arts et al., 2015a, 2015b; Kleinni-
jenhuis et al., 2012). H3K4me3 was, indeed, found to be signifi-
cantly increased at the promoters of mTOR, HK2, and PFKP, and
the decrease of H3K9me3 was even more pronounced (also for
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GLS and GLUD) (Figure 3B). When monocytes were trained
with BCG, an increase of H3K4me3 and a decrease of
H3K9me3 were found at the promoters of TNFA and IL6, just
as in previous findings (Arts et al., 2015a). However, when
BCG training was inhibited with metabolic inhibitors of glutamine
metabolism (BPTES) or mTOR/glycolysis (rapamycin), the epige-
netic changes at the promoter site of TNFA and IL6 were
reversed to the baseline status (Figures 3C and 3D). This shows
that the epigenetic and metabolic changes are intertwined and
highly dependent on each other.
Induction of Glycolysis Is Crucial for Trained Immunity
following BCG Vaccination of Human Volunteers
Next, we examined whether the increased cytokine production
ex vivo 2 weeks and 3 months following BCG vaccination (Klein-
nijenhuis et al., 2012) was accompanied by increased glycolysis.
Indeed, this seemed to be the case, as shown by higher lactate
concentrations in supernatants (Figure 4A) and higher expres-
sion of HK2 and PFKP in peripheral blood mononuclear cells
(PBMCs), isolated from BCG-vaccinated individuals. Expression
of GLS and GLUD, involved in glutamine metabolism, was not
significantly affected by BCG vaccination, but there was a
possible trend toward higher expression at 3 months (Figure 4B).
To examine these pathways in vivo, we next administered
metformin, an AMPK (AMP-activated protein kinase) activator
(and mTOR inhibitor), to healthy volunteers for 5 days and exam-
ined ex vivo induction of trained immunity with BCG (as shown in
Figure 1A). The use of metformin inhibited the induction of
trained immunity by BCG, as shown by a temporarily decreased
induction of cytokine responses and lactate production upon
secondary stimulation (Figure 4C).
Genetic Validation for a Role of Glycolysis Pathway in
Trained Immunity
As a final step, we examined whether genetic variation in meta-
bolic pathways affected in vitro training of monocytes by BCG: if
glycolysis and glutaminolysis are important for the induction of
trained immunity, then genetic variation of rate-limiting enzymes
in these pathways should modulate trained immunity. In order to
determine this, the effects of SNPs in mTOR, HK2, PFKP, GLS,
and GLUD1/2 on induction of IL-6 and tumor necrosis factor a
(TNF-a) after LPS restimulation of BCG-trained macrophages
were determined in a first cohort (n = 65), and significant asso-
ciations were confirmed in a second cohort (n = 49). SNPs in
mTOR showed modulation of trained immunity, but as numbers
of the homozygous genotypes were small and several mTOR
SNPs were in linkage disequilibrium, it is hard to draw strong
conclusions on the causative SNP (Figure S5). Three GLUD
SNPs were not associated with the induction of cytokine
production, and the effect observed in one of the two GLS
SNPs (rs7564529) was not validated in the second cohort. How-
ever, three SNPs in HK2 and one SNP in PFKP significantly
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Figure 4. The Role of Glycolysis in Proof-of-Principle Clinical Trials in Human Volunteers
(A) In a human BCG vaccination trial (Kleinnijenhuis et al., 2012), healthy volunteers were vaccinated with BCG, and at baseline and after 2 weeks and 3 months,
PBMCs were ex vivo restimulated, and lactate concentrations in the supernatants were assessed (mean ± SEM, n = 19). *p < 0.05, Friedman test and Dunn’s
post-test).
(B) In the same vaccination trial expression of HK2, PFKP, GLS, and GLUDwere determined in PBMCs (mean ±SEM, n = 6). *p < 0.05, Wilcoxon signed-rank test.
(C) In a separate human metformin trial, healthy volunteers were treated for 6 days with an increasing dose of metformin. At baseline (day 0), directly after
completedmetformin treatment (day 6), and 3 days (day 9) and 14 day (days 20) after metformin treatment, monocytes were isolated and ex vivo trainedwith BCG
(as shown in Figure 1A). TNF-a and IL-6 production after 24-hr restimulation with LPS were determined at day 7, and lactate production was assessed prior to
restimulation (day 6) (mean ± SEM, n = 11). *p < 0.05, Wilcoxon signed-rank test.
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modulated the induction of trained immunity, and this effect was
validated in the second cohort (Figure 5). Given the rate-limiting
role of these enzymes for glycolysis, these findings support
the essential role of glycolytic rate for the induction of trained
immunity.
DISCUSSION
BCG-induced trained immunity results in an increased respon-
siveness of monocytes and macrophages, with effector func-
tions such as cytokine production and reactive oxygen species
release being increased upon secondary stimulation with non-
related pathogens. Earlier studies have shown that trained im-
munity is caused by epigenetic rewiring at the chromatin level
(Kleinnijenhuis et al., 2012). In this paper, we show that the
change in inflammatory profile and the underlying epigenetic
changes are dependent on changes in cellular metabolism,
with an increase in glycolysis as central hallmark, but also
with the upregulation of glutamine metabolism and oxidative
phosphorylation. Furthermore, these metabolic changes were
also epigenetically mediated, hence showing a complex inter-
action between immunometabolic pathways and epigenetic
modifications.
The importance of cellular metabolism during immune cell
activation has received a lot of attention in the last years. Already
in the beginning of the past century, Otto Warburg showed that
tumor cells displayed a higher rate of glycolysis and less oxida-
tive phosphorylation compared to normal cells, a process called
theWarburg effect (Warburg et al., 1927).More recently, a similar
pattern has been described during activation of immune cells,
such as for proinflammatory M(IFNg) macrophages and acti-
vated lymphocytes (Pearce et al., 2013; Tan et al., 2015). More-
over, not only glucosemetabolism but also othermetabolic path-
ways play important roles in reprogramming and polarizing cells,
with fatty acid oxidation and oxidative phosphorylation being
essential for anti-inflammatory M(IL-4) macrophage polarization
(Galva´n-Pen˜a and O’Neill, 2014) and glutamine metabolism with
succinate accumulation involved in IL-1b production (Tannahill
et al., 2013). Recently, it was shown that the increase in
glycolysis in LPS-activated bone-marrow-derived macrophages
Figure 5. The Effect of SNPs in Glycolytic Genes on the Induction of Trained Immunity by BCG
Bloodwas drawn of healthy volunteers in 2011 (cohort 1) and 2015 (cohort 2) and SNPswere determined. Adherent monocytes were cultured in vitro as described
in Figure 1A. Three SNPs in HK2 (rs2229621 and 1807090 in linkage disequilibrium, R2 = 0.936) and one SNP in PFKP were found to affect the production of IL-6
and TNF-a in the supernatants upon LPS restimulation after BCG training in both cohorts (mean ± SEM). *p < 0.05, Wilcoxon signed-rank test.
See also Figure S5.
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(BMDMs) was also a result of altered activity of transcription fac-
tors, with a shift from Myc to HIF-1a-dependent transcriptional
regulation (Liu et al., 2016).
In the present study, we demonstrate that cellular metabolism
reprogramming is a central process involved in the induction
of trained immunity by BCG vaccination as well. BCG is the
most widely used vaccine worldwide, and many epidemiological
studies have demonstrated its capacity to protect against non-
mycobacterial infections as well (Aaby et al., 2011; Biering-Sør-
ensen et al., 2012). We have recently shown that BCG is a potent
inducer of trained immunity: understanding the pathways that
contribute to this effect of BCG is, thus, crucial for understanding
the induction of trained immunity in humans and, potentially, to
design approaches for vaccination and immunotherapy in pa-
tients. Through a complementary approach combining in vitro
experiments, BCG vaccination in mice, BCG proof-of-principle
studies in humans, and genetic validation, we demonstrate a
crucial role for the Akt/mTOR pathway inducing a high glycolytic
rate for the induction of trained immunity. In addition, glutamine
metabolism is also necessary for a full effective activation of
trained immunity. In a model with b-glucan-induced trained im-
munity, a long-term increase in glycolysis (and pro-inflammatory
phenotype) was also shown, which was also dependent on
mTOR/HIF-1a pathway (Cheng et al., 2014). Interestingly, how-
ever, in b-glucan-induced trained immunity, a clear Warburg ef-
fect was seen, with a high glycolytic rate but decreased oxidative
phosphorylation (Cheng et al., 2014). In contrast, BCG-induced
trained immunity induced both glycolysis and an increase in ox-
ygen consumption, arguing that different metabolic programs
can be induced by various training stimuli. Nevertheless, when
electron transport chain complex V was inhibited by oligomycin,
no effect on cytokine production was observed, and when
glucose metabolism was shifted from lactate production to the
TCA cycle (by DCA), a decrease in induction of cytokine produc-
tion was observed. This demonstrates that glycolytic rate and
lactate production aremore important for the induction of trained
immunity than oxidative phosphorylation and that mitochondrial
metabolism could be associated with carbon and not energy
metabolism highlighted by the relevance of glutamine in trained
immunity.
The effect of BCGon cellularmetabolism hasbeen little studied
so far. In a BCG vaccination trial, PBMCs showed a decreased
expression of glycolysis genes 2 days after vaccination, but they
were upregulated at 7 and 14 days post-vaccination (Matsumiya
et al., 2015). In our trial, we saw the upregulation of glycolysis
genes and a trend for glutaminolysis genes up to 3 months after
vaccination. However, this was performed in only 19 volunteers
at one fixed time point after ex vivo stimulation. Given the strong
variation in the human population, a larger trial with sequencing
data (and, preferably, also genetic analysis) is stronglywarranted.
Furthermore, in infection models with Mycobacterium tubercu-
losis and M. avium, an overall shift of glucose metabolism from
oxidative phosphorylation to fermentation (the Warburg effect)
has been reported, and this was linked to pro-inflammatory cyto-
kine production and bacterial survival (Appelberg et al., 2015;
Gleeson et al., 2016; Shi et al., 2015). However, how long these
shifts last and whether they are only an expression of the acute
immune reaction to the mycobacteria are unknown.
One of the important conclusions of the present study is
that these changes in cellular metabolism contribute to the
long-term epigenetic reprogramming of trained monocytes. Pre-
viously, we have already shown how b-glucan-induced trained
immunity results in metabolic changes (the Warburg effect),
which is the result of epigenetic modulation, e.g., increased
H3K4me3 and H3K27ac at promoter sites of essential glycolytic
genes (Cheng et al., 2014). We have now confirmed that compa-
rable epigenetic changes are induced in BCG-induced trained
immunity. Interestingly, however, these epigenetic changes
are, in turn, dependent on the induction of the metabolic path-
ways: if glycolysis or glutaminolysis is inhibited, changes in
H3K4me3 and H3K9me3 at promoter sites of IL6 and TNFA
are reversed, showing a link between these two regulatory
cellular processes. The relation between cellular metabolism
and the epigenetic landscape of cells has recently received
increased attention (Donohoe and Bultman, 2012; Hirschey
et al., 2015; Kaelin and McKnight, 2013). Methylation of histone
tails is regulated by lysine demethylases and histone methyl-
stransferases, whose activity is influenced by cellular metabo-
lites functioning as co-factors. For histone (and also DNA)
methylation, S-adenosyl methionine (SAM), derived from methi-
onine, serves as a methyl donor and co-factor (Kaelin and
McKnight, 2013). More than 200 mammalian genes have been
predicted to encode for SAM-dependent methyltransferases
(Petrossian and Clarke, 2011). Unfortunately, the regulation of
SAM in BCG-induced trained immunity is still unknown. Histone
Lys demethylases (KDMs) of the JmjC and JmjD family need
a-ketoglutarate as a co-factor for the demethylation process
(Lu et al., 2012). Metabolites with a similar molecular struc-
ture—such as fumarate, succinate, or 2-hydroxyglutarate—
can, in turn, serve as antagonizing factors (Lu et al., 2012; Xiao
et al., 2012), thereby inhibiting the demethylation process. More-
over, these metabolites not only affect histone demethylases
but also affect DNA demethylases (Xiao et al., 2012); therefore,
this leaves DNAmethylation and the effect of the changingmeta-
bolism on DNA methylation as an intriguing topic for future
research. In this respect, it is important to point out that glutami-
nolysis, which can lead to succinate accumulation (Tannahill
et al., 2013), when inhibited, abolished the upregulation of cyto-
kine production by BCG. These data argue that the metabolic
and epigenetic modifications are intertwined and that positive
feedback loops are likely to strengthen the trained immunity
phenotype. While we demonstrate here the impact of cellular
metabolism on histone modifications at the level of immune
gene promoters, epigenetic changes may be also induced in
rate-limiting metabolic enzymes. Further study is needed to
examine these possible effects.
In order to further demonstrate the importance of mTOR-
dependent glycolysis for the induction of trained immunity, we
show in a clinical trial that metformin (an mTOR inhibitor) admin-
istration can inhibit the induction of trained immunity. Finally, we
demonstrate that genetic polymorphisms in genes encoding for
the rate-limiting glycolysis enzymes HK2 and PFKP influence the
induction of trained immunity in monocytes from two cohorts of
healthy volunteers. Also, several SNPs in mTOR showed a ten-
dency toward modulation of trained immunity, but their impor-
tance remains to be demonstrated in larger studies.
2568 Cell Reports 17, 2562–2571, December 6, 2016
In conclusion, we show essential roles for glycolysis and gluta-
mine metabolism for the induction of trained immunity in human
monocytes by BCG. Induction of these pathways is regulated by
epigenetic mechanisms at the level of chromatin organization.
The next step should investigate the potential therapeutic
role that the modulation of these pathways may have during
vaccination.
EXPERIMENTAL PROCEDURES
Monocyte Isolation and Training Experiments
Buffy coats from healthy donors were obtained after written informed consent
(Sanquin Blood Bank, Nijmegen, the Netherlands; and Hospital de Braga,
Braga, Portugal). PBMC isolation was performed by dilution of blood in pyro-
gen-free PBS and differential density centrifugation over Ficoll-Paque density
gradient media (GE Healthcare). Cells were washed twice in PBS and resus-
pended in RPMI culture medium (Invitrogen) supplemented with 50 mg/mL
gentamicin, 2mMglutamax (GIBCO), and 1mMpyruvate (GIBCO). In some ex-
periments, the glutamax was replaced with 2 mM or 1 mM L-glutamin (Sigma-
Aldrich). Subsequently, monocyte isolation was performed by hyper-osmotic
Percoll (Sigma) density gradient centrifugation. Afterward, cells were washed
oncewithPBS.Monocyteswere counted andadjusted to13106 cells permilli-
liter. A100-mLvolumewasadded to flat-bottomed96-well plates (Corning), and
cellswere allowed to adhere for 1 hr at 37C; subsequently, awashing stepwith
200 mL warm PBS was performed to yield maximal purity. Monocytes were
incubated with culture medium only, as a negative control, or 5 mg/mL of
BCG (SSI) for 24 hr (in 10% pooled human serum). Cells were washed once
with 200mLwarmPBSand rested for 5days in culturemediumwith 10%human
pooled serum. Medium was changed once on day 3 of incubation. On day 6,
cells were re-stimulated for 24 hr with 200 mL RPMI or 10 ng/mL Escherichia
coli LPS (serotype 055:B5, Sigma-Aldrich), after which supernatants were
collected and stored at20C. In some experiments, cells were pre-incubated
(before BCG training) for 1 hr with 100 nMWortmannin (Sigma), 10 nM rapamy-
cin (Sigma), 50 mM BPTES (Sigma), 100 mM 6-aminonicotinamide (Sigma),
11mM2-deoxyglucose (Sigma), 0.3mMmetformin, 3mMpotassiumdichloroa-
cetate (DCA, Sigma), 1 mM AICAR (5-aminoimidazole-4-carboxamide-1-b-D-
ribofuranoside, BrunschwigChemie), 10 nMTorin 1 (R&DSystems), 1mMoligo-
mycin (Sigma).
Cytokine, Lactate, Glucose, and NAD+ Measurements
Cytokine production was determined in supernatants using commercial ELISA
kits for TNF-a (R&D Systems) and IL-6 (Sanquin), following the instructions of
the manufacturer. Lactate, glucose, and NAD/NADH concentrations were
measured using Fluorometric Quantification Assay Kits (Biovision).
Metabolite Measurements
10 3 106 monocytes were trained in 10-cm Petri dishes (Greiner) in 10-mL
medium volumes. At day 6, cells were detached from the plate with Versene
solution (Life Technologies) and counted. At least 1 million cells were lysed
in 60 mL 0.5% Triton X-100 in PBS. Metabolite concentrations were deter-
mined by assay kits for fumarate, glutamate, malate, or acetyl-CoA (all Sigma),
following the instructions of the manufacturer.
Western Blots
Monocytes were cultured as described earlier, and after 4 hr (Akt) or 6 days
(mTOR), cells were lysed and stored at 80C. Total protein amounts were
determined by Pierce BCA Protein Assay Kit (Thermo Fisher Scientific),
and equal amounts of proteins were loaded on precasted 4%–15% gels
(Bio-Rad). The separated proteins were transferred to a nitrocellulose mem-
brane (Bio-Rad), which was blocked in 5% BSA (Sigma). Incubation overnight
at 4C with rabbit polyclonal antibodies against phosphorylated (p-)Akt,
p-mTOR, p-S6K, p-4EBP1 (Cell Signaling), and actin (Sigma) was used to
determine the protein expression, which was visualized using a polyclonal
secondary antibody (Dako) and SuperSignal West Femto Substrate (Thermo
Fisher Scientific) or ECL (Bio-Rad).
mRNA Extraction and RT-PCR
Cells were cultured as described earlier. On day 6, mRNA was extracted by
TRIzol (Life Technologies), according to the manufacturer’s instructions, and
cDNA was synthesized using iScript Reverse Transcriptase (Invitrogen). Rela-
tive expression was determined using the SYBR Green method (Invitrogen) on
an Applied Biosciences StepOne PLUS qPCRmachine, and the values are ex-
pressed as fold increases in mRNA levels, relative to those in non-trained cells,
with HPRT as a housekeeping gene. Primers are listed in Table S1.
Chromatin Immunoprecipitation
10 3 106 monocytes were trained in 10-cm Petri dishes (Greiner) in 10-mL
medium volumes. Cells were isolated and trained as described earlier. After
resting for 5 days in culture medium, the cells were harvested and fixed in
1% methanol-free formaldehyde. Afterward, cells were sonicated, and immu-
noprecipitation was performed using antibodies against H3K4me3 and
H3K9me3 (Diagenode). DNA was isolated with the MinElute PCR Purification
Kit (QIAGEN) and was further processed for qPCR analysis using the SYBR
Green method. Samples were analyzed by a comparative Ct method accord-
ing to the manufacturer’s instructions. The primers are listed in Table S1.
Assessment of Glycolysis and Oxygen Consumption by Seahorse
Methodology
103 106 monocytes were trained in 10-cm Petri dishes (Greiner) in 10-mLme-
dium volumes as described earlier and, after 6 days, were detached with Ver-
sene solution (ThermoFisher Scientific) from the culture plates. 100,000 cells in
triplicate were plated to overnight-calibrated cartridges in assay medium
(RPMI with 0.6 mM glutamine, [pH adjusted to 7.4]; for OCR, 5 mM glucose
and 1 mM pyruvate were also added) and incubated for 1 hr in a non-CO2-cor-
rected incubator at 37C. OCR and ECAR were analyzed using a Cell Mito
Stress Kit (for OCR) or a glycolysis stress test (for ECAR) kit in an XFp Analyzer
(Seahorse Bioscience), with final concentrations of 1 mM oligomycin, 1 mM
FCCP, 0.5 mM rotenone/antimycin A, 10 mM glucose, and 50 mM 2-DG.
For Seahorse mouse ex vivo analyses, splenocytes were collected from
either BCG-vaccinated or control mice and plated 4 3 105 cells per well in
RPMI medium supplemented with 10% FBS. At 12 hr, cells were analyzed
with a 96XFe analyzer to assess ECAR and OCR, as described earlier.
Animal Experiments
This article conforms to the relevant ethical guidelines for animal research.
The research was approved by the Institutional Animal Care Committee of
the Italian Ministry of Health (No. 220/2010-B), and the handling of mice was
conducted in compliance with European Community Directive 86/609 and
the American Association for Laboratory Animal Science’s recommendations
for the care and use of laboratory animals.
Briefly, C57BL/6 female mice were supplied as specific pathogen-free mice
by Charles River Laboratories and were maintained in specific-pathogen-free
conditions. Food and water were available ad libitum. 5 week-old mice were
vaccinated, or not vaccinated, with a single dose of BCG (53 106 colony-form-
ing units [CFU] in 200 mL PBS) injected intravenously (i.v.). Five mice were used
for each experimental mouse group. Seven days after BCG vaccination, mice
were sacrificed by cervical dislocation, in accordance with the ethics require-
ments, and spleens were aseptically collected. Single-cell suspensions were
prepared in PBS by mechanic dissociation (gentleMACS dissociator) and
applied to Falcon 2360 cell strainers (BD Discovery Labware) before being
used in Seahorse experiments.
NMR and Amino Acid Experiments
Amino acids were quantified by high-performance liquid chromatography
(HPLC) in a Gilson UV/VIS-155 detector (338 nm) after precolumn derivatiza-
tion with ortho-phthalaldehyde (OPA, with methanol R 99.9%, potassium
borate [1 M, pH = 9.5], and 2-mercaptoethanol R 99.0%) at a 1:5 ratio
(Sigma-Aldrich). Culture supernatants were filtered by Acrodisc 13-mm sy-
ringe filters with a 0.2-mm Supor membrane (Pall Corporations). The inorganic
mobile phase (pH = 7.8) was composed by a Na2HPO4 , 2H2O3 (50 mM):
propionic acid (250 mM) (1:1) mixture (Merck) with HPLC-grade acetonitrile
in water (10:2:13). The organic mobile phase was composed by acetonitrile,
methanol, and water (3:3:4) (HPLC grade, HiPerSolv Chromanorm, VWR
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Chemicals). All mobile phases for elution were degasified for 30 min prior to
analysis. Amino acids were quantified using the Gilson Uniprot software,
version 5.11; and accordingly, standard solutions were prepared in MilliQ
water (Millipore).
For NMR spectroscopy, methanol/water extracts and cell culture superna-
tants were analyzed. The aqueous and chloroform extracts were dried in a
SpeedVac Plus system. The aqueous extract was suspended in 600 mL D2O
with 0.262 mM of TSP-d4 as chemical shift indicator and the organic extract
in 600 mL CD3Cl. To 550 mL cell culture media 50 mL D2O was added, with a
TSP-d4 final concentration of 0.262 mM.
The samples were analyzed at 25C by 1H NMR (nuclear magnetic reso-
nance) and by 2D 13C-1H heteronuclear single-quantum coherence (HSQC)
spectroscopy in an Ultrashield Plus 800 MHz spectrometer (Bruker) operating
at 800.33 MHz, equipped with a TXI-Z H C/N/-D (5-mm) probe. The 1H NMR
pulse sequence used has a NOESY (nuclear Overhauser effect spectroscopy)
presaturation (noesygppr1d) with irradiation at the water frequency (number
of scans [ns] 124, time domain [TD] 64K, sweep width [SW] 20 ppm, relaxation
delay [d1] 4 s, d8 0.01 s), while the 13C-1H HSQC used the hsqcetgpsisp2
pulse sequence (ns 16, TD1 512, TD2 2K, SW2 16 ppm, SW1 165 ppm, d1
1 s). The chemical shifts in the aqueous sample were referred to TSP (trime-
thylsilyl proprionate). Spectra were acquired and processed using TopSpin
3.2 software (Bruker); assignments were made by comparison with chemical
shifts found in the literature for metabolic intermediates and Human Metabo-
lome Database (http://www.hmdb.ca). The quantifications of the signals were
performed by integration of the peaks in the 1H-NMR spectra and of the vol-
umes in the 13C-1H-HSQC spectra, using the resonance due to the TSP as
reference.
Ex Vivo Studies in Humans
In the BCG vaccination trial, 20 healthy volunteers were vaccinated with the
BCG vaccine (SSI) after informed consent was obtained. Before vaccination
and at 2 weeks post- and 3 months post-vaccination, blood was drawn and
PBMCs were isolated and stimulated ex vivo with M. tuberculosis, S. aureus,
or C. albicans. 24-hr supernatants were used to determine lactate production,
and PBMCs were stored in TRIzol to determine gene expression. The study
was approved by the Arnhem-Nijmegen Medical Ethical Committee
(NL31936.091.10). Primary endpoints and detailed methods were published
previously (Kleinnijenhuis et al., 2012).
In the metformin clinical trial, 12 healthy non-obese volunteers with good
kidney function and devoid of metabolic disorders received increasing
amounts of metformin for a total of 5 days (1,000 mg on day 1; 2,000 mg on
day 6). Blood sampling was performed 1 day before the start of metformin
(day 0), directly after metformin intake (day 6), on day 9, and on day 20 for
ex vivo training of isolated monocytes. The study was approved by the Arn-
hem-Nijmegen Medical Ethical Committee (NL47793.091.14). Both studies
were conducted in accordance with the Helsinki Declaration.
Genetic Analysis
For the genetic studies, we investigated genetic variation in two cohorts of
healthy Dutch volunteers described previously (Li et al., 2016; Oosting et al.,
2010, 2014): one cohort of 65 volunteers (cohort 1) collected in 2011, and a
second cohort of 49 volunteers collected in 2015 (cohort 2). In both cohorts,
we performed ex vivo trained immunity experiments. Volunteers were between
23 and 73 years old and consisted of 77% men and 23% women. Monocytes
were cultured in vitro as described earlier. SNPs in the database for mTOR,
HK2, PFKP, GLS, and GLUD1/2 were selected to analyze their effect on IL-6
and TNF-a production upon LPS restimulation after BCG training. SNP infor-
mation was extracted from a genome-wide Illumina Infinium SNP array (Parkes
et al., 2013). Linkage disequilibrium was calculated according to the methods
of Machiela and Chanock (2015).
Statistics
Ex vivo and in vitro monocyte experiments were performed at least six times
and analyzed using a Wilcoxon signed-rank test or one-way ANOVA, where
applicable. A p value below 0.05 was considered statistically significant;
*p < 0.05, and **p < 0.01. All data were analyzed using GraphPad prism 5.0.
Data are shown as means ± SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and one table and can be found
with this article online at http://dx.doi.org/10.1016/j.celrep.2016.11.011.
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